Assessment of residual symptoms using the Okomarigoto Sheet can complement evaluation of the Patient Acceptable Symptom State in patients with rheumatoid arthritis

The complete absence of residual symptoms, as measured by the OS, was strongly associated with achieving PASS, even among patients in SDAI-defined remission. Systematic evaluation and targeted management of residual symptoms may improve patient satisfaction and facilitate shared decision-making in RA care.